Sydney:The University of Sydney has unveiled results from a comprehensive Australian clinical trial that investigated symptom monitoring and quality of life for patients undergoing dialysis due to kidney failure.
According to Saudi Press Agency, the trial included 2,412 haemodialysis patients across Australia and was conducted in partnership with the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).
The study was executed through the Sydney Clinical Trials Centre with funding from the National Health and Medical Research Council (NHMRC). It utilized electronic patient-reported outcome measures to systematically record patient symptoms, providing feedback and evidence-based guidance for managing these symptoms to both patients and clinicians.
The results indicated that while symptom monitoring and feedback facilitated more discussions between nephrologists and their patients regarding symptoms, there was no significant improvement in the overall health-related quality of life or fatigue levels among patients.
Additionally, the trial demonstrated the feasibility of routinely collecting patient-reported outcomes on a large scale across diverse dialysis centers, including those in regional and remote areas. Lead researcher Professor Rachael Morton presented these findings at the American Society of Nephrology meeting in Denver, United States.